Development of Protacs to target cancer-promoting proteins for ubiquitination and degradation

KM Sakamoto, KB Kim, R Verma, A Ransick… - Molecular & Cellular …, 2003 - ASBMB
The proteome contains hundreds of proteins that in theory could be excellent therapeutic
targets for the treatment of human diseases. However, many of these proteins are from …

[HTML][HTML] Estradiol and selective estrogen receptor modulators differentially regulate target genes with estrogen receptors α and β

MK Tee, I Rogatsky, C Tzagarakis-Foster… - Molecular biology of …, 2003 - Am Soc Cell Biol
Estrogens and selective estrogen receptor modulators (SERMs) interact with estrogen
receptor (ER) α and β to activate or repress gene transcription. To understand how …

Global analysis of ligand sensitivity of estrogen inducible and suppressible genes in MCF7/BUS breast cancer cells by DNA microarray

KR Coser, J Chesnes, J Hur, S Ray… - Proceedings of the …, 2003 - National Acad Sciences
To obtain comprehensive information on 17β-estradiol (E2) sensitivity of genes that are
inducible or suppressible by this hormone, we designed a method that determines ligand …

Chemoprevention of breast cancer and the trials of the National Surgical Adjuvant Breast and Bowel Project and others.

RE Smith, BC Good - Endocrine-related cancer, 2003 - erc.bioscientifica.com
The idea of breast cancer prevention by hormonal means stemmed from the results of
treatment trials, many of them carried out by the National Surgical Adjuvant Breast and …

A review of selective estrogen receptor modulators and national surgical adjuvant breast and bowel project clinical trials

RE Smith - Seminars in oncology, 2003 - Elsevier
Over the last 20 years tamoxifen, a selective estrogen receptor modulator, has been shown
to be of clinical benefit to patients with advanced and resected hormone receptor-positive …